NASDAQ:MREO | Balance Sheet | Mereo BioPharma Group plc

Complete source-backed balance-sheet history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$30.12M$33.4M$54,000.00$34.71M$1.12M$5.68M$370,000.00$6.06M$28.65M
2026-03-31$30.1M$40.03M$91,000.00$40.61M$3.23M$6.18M$362,000.00$6.56M$34.05M
2025-12-31$40.99M$45.02M$137,000.00$45.92M$1.33M$4.3M$661,000.00$5M$40.92M
2025-09-30$48.7M$52.41M$174,000.00$53.6M$879,000.00$6.02M$652,000.00$7M$46.6M
2025-06-30$56.13M$61.42M$218,000.00$62.63M$1.14M$7.56M$352,000.00$8.45M$54.18M
2025-03-31$62.48M$66.9M$247,000.00$68.32M$2.92M$7.5M$325,000.00$8.24M$60.08M
2024-12-31$69.8M$74.76M$257,000.00$76.39M$2.44M$13.85M$565,000.00$15.42M$60.97M
2024-09-30$80.52M$86.72M$315,000.00$88.75M$1.75M$14.21M$568,000.00$16.21M-$72.54M
2024-06-30$87.43M$93.94M$338,000.00$96.13M$2.7M$15.47M$536,000.00$17.48M$78.65M
2024-03-31$48.66M$53.5M$360,000.00$55.94M$2.46M$11M$513,000.00$13.1M$42.84M
2023-12-31$57.42M$63.76M$405,000.00$66.5M$2.35M$9.49M$764,000.00$15.96M$50.54M
2023-09-30$54.71M
2023-06-30$49.67M
2023-03-31$44.4M
2022-12-31$68.18M$75.2M$551,000.00$77.41M$3.49M$24.38M$0.00$26.01M$51.4M
2021-12-31$92.2M